1. Chemotherapy Versus Chemoradiation as Preoperative Therapy for Resectable Pancreatic Ductal Adenocarcinoma: A Propensity Score Adjusted Analysis. Issue 2 (February 2019) Authors: Cloyd, Jordan M.; Chen, Hsiang-Chun; Wang, Xuemei; Tzeng, Ching-Wei D.; Kim, Michael P.; Aloia, Thomas A.; Vauthey, Jean-Nicolas; Lee, Jeffrey E.; Katz, Matthew H.G. Journal: Pancreas Issue: Volume 48:Issue 2(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Eye movement indices of memory reveal re-processing of visual information: Evidence from Chinese characters. Issue 7 (9th August 2018) Authors: Lee, Yuh-shiow; Chen, Hsiang-Chun Journal: Visual cognition Issue: Volume 26:Issue 7(2018) Page Start: 500 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Hypertension and Circulating Cytokines and Angiogenic Factors in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma Treated With Sunitinib: Results From a Phase II Trial. (25th August 2015) Authors: Bilen, Mehmet Asim; Zurita, Amado J.; Ilias-Khan, Nasreen A.; Chen, Hsiang-Chun; Wang, Xuemei; Kearney, Alper Y.; Hodges, Sherie; Jonasch, Eric; Huang, Shixia; Khakoo, Aarif Yusuf; Tannir, Nizar M. Journal: Oncologist Issue: Volume 20:Number 10(2015) Page Start: 1140 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Minimally invasive management of the entire treatment sequence in patients with stage IV colorectal cancer: a propensity-score weighting analysis. Issue 12 (December 2018) Authors: Goumard, Claire; Nancy You, Y.; Okuno, Masayuki; Kutlu, Onur; Chen, Hsiang-Chun; Simoneau, Eve; Vega, Eduardo A.; Chun, Yun-Shin; David Tzeng, C.; Eng, Cathy; Vauthey, Jean-Nicolas; Conrad, Claudius Journal: HPB Issue: Volume 20:Issue 12(2018) Page Start: 1150 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer. Issue 1 (December 2016) Authors: Powell, Emily; Shao, Jiansu; Yuan, Yuan; Chen, Hsiang-Chun; Cai, Shirong; Echeverria, Gloria; Mistry, Nipun; Decker, Keith; Schlosberg, Christopher; Do, Kim-Anh; Edwards, John; Liang, Han; Piwnica-Worms, David; Piwnica-Worms, Helen Journal: Breast cancer research Issue: Volume 18:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial. Issue 9 (September 2021) Authors: de Bono, Johann S; Mehra, Niven; Scagliotti, Giorgio V; Castro, Elena; Dorff, Tanya; Stirling, Adam; Stenzl, Arnulf; Fleming, Mark T; Higano, Celestia S; Saad, Fred; Buttigliero, Consuelo; van Oort, Inge M; Laird, A Douglas; Mata, Marielena; Chen, Hsiang-Chun; Healy, Cynthia G; Czibere, Akos; Fiz... Journal: Lancet oncology Issue: Volume 22:Issue 9(2021) Page Start: 1250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗